Last reviewed · How we verify

NCT06795672

Tele-rehabilitation for Cognitive Disorders

Terminated NA Last updated 28 January 2025
What this trial tests

NA trial testing Telerehabilitation in Rehabilitation in 23 participants. Terminated before completion.

Timeline
28 March 2022
Primary endpoint
31 March 2024
31 March 2024

Quick facts

Lead sponsorUniversita di Verona
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment23
Start date28 March 2022
Primary completion31 March 2024
Estimated completion31 March 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Universita di Verona — full company profile →

Who can join

Adults 18 to 90, any sex, with Rehabilitation or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate whether a computer-based cognitive treatment delivered via tele-rehabilitation produces an improvement in cognitive functioning comparable to the improvement achievable through the same treatment delivered in person in patients with stroke outcomes. To investigate, using a custom-designed questionnaire, the feasibility and patient satisfaction with the rehabilitative treatment delivered via telemedicine compared to the same treatment delivered in person.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Telerehabilitation

Trials testing the same drug.

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

Other Universita di Verona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06795672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing